The effect of androgen deprivation and radiation therapy on an androgen- sensitive murine tumor: An in vitro and in vivo study

Cancer Journal from Scientific American

Volumn 3, Issue 1, 1997, Pages 31-36

  Zietman, Anthony L ^a,b   Nakfoor, Bruce M ^a   Prince, Ethan A ^a   Gerweck, Leo E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

androgen deprivation; radiation therapy; Shionogi tumor

Indexed keywords

ANDROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; COLONY FORMATION; CONTROLLED STUDY; HORMONE DEPENDENCE; MALE; MOUSE; NONHUMAN; ORCHIECTOMY; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; TUMOR GROWTH;

ANDROGENS; ANIMALS; CELL SURVIVAL; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; ORCHIECTOMY; TESTOSTERONE; TUMOR CELLS, CULTURED;

EID: 0030934512     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bagshaw MJ, Cox RS, Hancock SL. Control of prostate cancer with radiotherapy: long-term results. J Urol 1994;152:1781-1785.
2. Zietman AL, Coen JJ, Dallow KA et al. The treatment of prostate cancer by conventional radiation therapy: an analysis of long term outcome. Int J Radiat Oncol Biol Phys 1995;32:287-292.
3. Daneshgari F, Crawford ED. Endocrine therapy of advanced cancer of the prostate. Cancer 1993;71:1089-1097.
4. Sneller Z, Hop WC, Carpentier P et al. Prognosis and prostate volume changes during endocrine management of prostate carcinoma: a longitudinal study. J Urol 1992;147:962.
5. Suit HD, Shalek RJ, Wette R. Radiation response of C3H mouse mammary carcinoma evaluated in terms of cellular radiosensitivity. In: Shalek RJ et al, eds. Cellular Radiation Biology. Baltimore: Williams & Wilkins Co., 1965:514-530.
6. Pilepich MV, Krall JM, Al-Sarraf M et al. Androgen deprivation with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 1995;45:616-623.
7. Dahiya R, Zhang DY, Ho RJ et al. Regression of LNCaP human prostate tumor xenografts in athymic nude mice by 13-cis-retinoic acid and androgen ablation, Biochemistry and Molecular Biology International 1995;35:487-498.
8. Lim DJ, Liu XL, Sutkowski DM et al. Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice. Prostate 1993;22:109-118.
9. Bruchovsky N, Rennie PS, Coldman AJ et al. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res 1990;50:2275-2282.
10. Minesita T, Yamaguchi T. An androgen-dependent mouse mammary tumor. Cancer Res 1965;25:1168-1175.
11. Gerweck LE, Dublea R, Zaidi ST et al. Influence of experimental factors on intrinsic radiosensitivity assays at low doses of radiation: cell multiplicity. Radiat Res 1994;138:361-366.
12. Adams GE, Dische S, Fowler JF et al. Hypoxic cell sensitizers in radiotherapy. Lancet 1976;186-188.
13. Chapman JD, Whitmore GF. Chemical modifiers of cancer treatment. Int J Radiat Oncol Biol Phys 1984;10:1161-1813.
14. Chung LWK. The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv 1995;23:33-42.
15. Gleave ME, Hsieh JT, Gao C et al. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res. 1991;51:3753-3761.
16. Pretlow TG, Delmoro CM, Dilley GG et al. Transplantation of human prostatic carcinoma into nude mice in matrigel. Cancer Res 1991;51:3814-3817.
17. Gleave M, Goldenberg SL, Jones EC et al. Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer. J Urol 1996; 155:213-219.
18. Laverdiere J, Gomez JL, Cusan L et al. Beneficial effect of combination therapy administered prior and following external beam radiation therapy in localized prostate cancer (abstract). Int J Radiat Oncol Biol Phys 1995;32:189.